Grace Therapeutics (GRCE) Gross Margin (2020 - 2021)
Grace Therapeutics (GRCE) posted Gross Margin of 65.22% for fiscal Q4 2021 (quarter ended Mar 31, 2021), up 9.66 percentage points from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Gross Margin (2020 - 2021) Analysis & Trends
For FY2021 (ended Mar 31, 2021), Grace Therapeutics' Gross Margin came in at 61.22%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 72.78% |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | - |
API Access
Grace Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();